Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

21 October 2002

Locomotion of human granulocytes in viscous media.

Jadwiga Jakubas-Przewłocka

Med Sci Monit 2002; 8(10): BR408-413 :: ID: 4876

Abstract

BACKGROUND: Granulocytes must migrate to the infection site, where they phagocytose the infecting agents. Their ability to migrate depends on the rheological properties of the cells, which change along with the increased viscosity of the suspension medium. The purpose of this research was to study the influence of medium viscosity on granulocyte locomotion. MATERIAL/METHODS: The random locomotion of human granulocytes was investigated by means of an assay based on direct observation of individual cell trajectories. The study was performed in viscous media, ranging from 0.7 x 10(-3) to 370 x 10(-3) Pa x s (0.7-370 cP). Hanks solution, supplemented with methylcellulose in various concentrations, was used as a medium. The locomotion of several hundred granulocytes was studied, and about 7,000 cell track-sections (steps) were recorded. RESULTS: The mean granulocyte velocity decreases slowly with increasing medium viscosity. An increase in medium viscosity of ca. 500 times results in only a three-fold reduction in velocity. Granulocytes can migrate even at the viscosity of thick honey. They are capable of overcoming resistance forces on the order of 10(-11)N. The locomotion of granulocytes in dextran and ficoll media is also described. In these media both viscosity and osmotic pressure were variable. Granulocytes stop moving at very low viscosity, on the order of 10(-3) Pa x s. CONCLUSIONS: The locomotion of granulocytes is not stopped even in media of high viscosity. The observed decrease of granulocyte velocity is comparatively small. The studies in dextran and ficoll media indicate significant influence of osmotic pressure on granulocyte locomotion.

Keywords: Granulocytes - physiology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750